Public Service Co. of Oklahoma has applied to the state Corporation Commission for an “adjustment” in its rates that would ...

Pearson plc is leveraging AI-driven efficiency and digital transformation to drive sustained margin expansion and free cash flow growth. Learn more about PSO stock here.

Takeda Canada Inc. ("Takeda") is pleased to announce new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), ...

71.4% and 69.2% of patients treated with zasocitinib achieved a static Physician Global Assessment (sPGA) score of 0/1 versus placebo (10.7% and 12.6%) and apremilast (32.1% and 29.7%) at week 16 (p<0 ...

Scholastic's TV app nears 100M minutes watched and 800+ episodes, and Entertainment revenues rise 25%, but scaling in streaming remains the test.

Once-daily oral zasocitinib for moderate to severe plaque psoriasis demonstrated rapid and durable skin clearance and a ...

Pakistan’s oil marketing companies (OMCs) recorded a strong rebound in March 2026, with total sales rising 19% year-on-year ...

Two Phase 3 clinical studies evaluated the efficacy and safety of zasocitinib in patients with moderate to severe plaque psoriasis and found promising results. Approximately 70% of ...

In east Tulsa, concerns are mounting as construction continues on a large-scale development and now a city councilor said ...

Bulls roared back at the Pakistan Stock Exchange (PSX) amid hopes of a de-escalation in the Iran-US war, with the benchmark ...

Johnson & Johnson presents new data showing high rates of complete skin clearance achieved at Week 24 and Week 52 in ICONIC-ADVANCE 1 and 2 studies Nearly 60% of adolescents treated with ICOTYDE ...

High rates of complete skin clearance achieved at Week 24 and Week 52 in ICONIC-ADVANCE 1 and 2 studies.- Completely clear skin achieved at Week 52 in nearly 60% of adolescents treated with ...